Singapore approves use of world's first dengue vaccine

By LINETTE LAI

- AFP

SINGAPORE: The Health Sciences Authority (HSA) has approved the world's first dengue vaccine Dengvaxia for use in Singapore following a seven-month expedited review of the potential benefits and risks.

It will be made commercially available in several months' time.

The Star Christmas Special Promo: Save 35% OFF Yearly. T&C applies.

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Health , Singapore , Health Sciences Authority , Dengue fever , Vaccine , Dengvaxia

Next In Regional
China delays plans for mass production of self-driving cars after accident
As US battles China on AI, some companies choose Chinese
Does China have a robot bubble?
Social app RedNote expanding beyond China despite privacy concerns
China's smaller manufacturers look to catch the automation wave
China public servants use face masks to bypass facial recognition to help each other skip work
Taiwan RedNote ban backfires, driving mainland Chinese app’s top download rise
Chinese smart glasses firms eye overseas conquest
India says mandatory phone app can be deleted after backlash
120,000 home cameras were hacked for sexual videos, South Korean police say

Trending in News

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.